Here are five biotechs that smashed the ASX200’s performance in 2018

Health stocks don’t get the investor appreciation that battery metals do these days — but a key index of 40 ASX biotechs shows they are making strong returns. Biotech Daily’s index of 40 key ASX biotech stocks finished up 18 per cent for the year to June 30, while the ASX-200 returned 8 per cent, says … Continue reading Here are five biotechs that smashed the ASX200’s performance in 2018

Do NOT follow this link or you will be banned from the site!